DementiaNCT04935060
Sharing the Outcome of a Memory Assessment
A study testing A guide to inform the process of delivering the outcomes of a dementia assessment in people with Dementia, run by University of Nottingham at 2 sites in United Kingdom.
Trial summary
The purpose of this study is to establish the acceptability of a guide developed to improve people's experiences of dementia assessment outcome appointments in comparison to a standard consultation. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Dementia
- What is being tested?
- A guide to inform the process of delivering the outcomes of a dementia assessment
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 7 participants
- Where
- 2 sitesUnited Kingdom
- Study dates
- 21 Sep 2021to 4 May 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Patients will be included in the study if they are:
- Taking part in an initial assessment appointment with the participating MAS services
- Aged 18 years or over (Northamptonshire MAS require patients to be 65 years or over to be eligible for referral. There will be no upper age limit)
- Able to provide written informed consent
- Companions will be included in the study if they are:
- Supporting a patient-participant to attend a MAS initial assessment appointment
Show all 11Show fewer
- Aged 18 years or over
- Able to provide written, informed consent
- MAS Clinicians will be included in the study if they are:
- Involved in the delivery of MAS outcome appointments
- Able to provide written informed consent
Who cannot join
- Patients and companions will not be included in the research if there is reason to doubt their capacity to give informed consent under the Mental Capacity Act 2005.
- Patients and companions who are not fluent in English will not be included in the study.
Trial locations and contacts
2 sites in 1 country.
United Kingdom2 sites
Memory Assessment Service (Corby/Kettering)
Corby, Northamptonshire, NN17 1RJ
Memory Assessment Service (Rushden/Wellingborough)
Rushden, Northamptonshire, NN10 0PT
About this study
Official title: The Acceptability and Feasibility of a Guide for Sharing the Outcome of a Memory Assessment
The purpose of this study is to establish the acceptability of a guide developed to improve people's experiences of dementia assessment outcome appointments in comparison to a standard consultation. This study will also inform the feasibility of future research evaluating the guide and provide information on how well the measurements used provide evaluation of the intervention.
Read the detailed description
Objectives:
To determine the acceptability of a guide supported consultation (intervention) for clinicians, patients and companions, in comparison to a standard diagnostic consultation (usual care).
To inform the feasibility of future research establishing recruitment processes and study uptake.
To establish how well the chosen measurement strategy provides evaluation of the intervention (including completion rates, perceived relevance and burdensomeness).
Setting:
NHS Secondary care, Memory Assessment Service (MAS). Services within the identified area are split into four teams. One team will provide the usual care treatment arm. Another team will provide the intervention arm.
Number of participants:
24 Patients and 24 Companions will be recruited for the quantitative component of the study.
Two clinicians and six participants will be recruited for the qualitative component of the study.
Description of interventions:
Baseline Measurement The Consultation and Relational Empathy (CARE) questionnaire and the adapted CARE (for companions) will be used to collect baseline data for each of the two sites. Baseline data will be collected from anyone attending outcome appointments at both sites during a recruitment period prior to the implementation of the intervention and will form an initial baseline cohort.
Quantitative Data Collection Usual Care Procedure The usual care procedure involves assessment of patient's cognitive abilities, daily functioning and physical health to determine the possibility of them having a dementia. This is done through a detailed history taking by MAS clinicians including information given by the patient, companions and information included from a GP referral. Standardised assessments are also conducted to inform the assessment process. These assessments are used based on the needs of the patient and companions involved. Access to scores on these assessments will be gained through their medical records and will provide a measurement for comparison between the two groups.
MAS outcome appointments are provided as part of routine care. These appointments require clinicians to rely on their professional judgement of the best way for the outcomes of assessments to be communicated to patients and their companions. There are no current standardised guidelines used within the service for this purpose.
In addition to the service's usual practice, participants will be asked to complete the CARE and the adapted CARE following their initial assessment and their outcome appointment. The completed questionnaires will be returned to the researcher by post via pre-paid envelope. A reminder via telephone call will be given to participants on the day following their appointment and if they haven't completed the questionnaire they will be given the opportunity to complete it whilst on the call with the researcher.
Intervention Procedure The intervention procedure will follow the same steps as the usual care procedure with the addition of use of the Bennett, De Boos and Moghaddam (2018) guide for clinicians, patients and companions. After gaining of written consent at the initial assessment appointment, the clinician will give the patient a copy of the guide and inform them that they can share this with their companion should they wish to. When conducting outcome appointments clinicians will use the guide to inform communication with the patient and companion. Clinicians will also refer patients and companions to their copy of the guide during the outcome appointment.
Qualitative Data Collection Qualitative data will be collected using semi-structured interviews with patients and companions as well as clinicians focussing on their experiences of the outcome appointment. Individuals taking part in the interviews will be involved will therefore be involved with the study for a further four weeks.
Duration of study:
Overall: March 2021-February 2022 Participants and companions involvement with the study will be for the duration of their assessment by the MAS teams. This is usually around 16 weeks but varies depending on the clinical needs of the patient. Participants taking part in the additional qualitative interview will extend the duration of their involvement in the study by up to four weeks.
Statistical Methods Quantitative data analysis Quantitative analysis will be descriptive and will aim to give confidence interval estimation. Baseline measures will be collected for each location to allow estimates of the variability between the two sites for comparison.
Intra Class Correlations (ICCs) will be carried out to examine the degree of clustering. Intention to treat (ITT) analysis will be carried out to give a more accurate estimate of effectiveness in clinical practice. Participants data will be analysed based on their experimental arm allocation.
Intra Class Correlations (ICCs) will be carried out to examine the degree of clustering. Intention to treat (ITT) analysis will be carried out to give a more accurate estimate of effectiveness in clinical practice. Participants data will be analysed based on their experimental arm allocation.
Viability of recruitment will be assessed using eligibility and consent rates for patients and clinicians. The burden of measure completion will be assessed through missing data levels as well as interviews with patients and clinicians. Withdrawal rates post consent will be calculated by study arm for use in future sample size calculations.
Qualitative data analysis A framework method, as set out by Ritchie and Spencer (1994), will be used to identify themes. This will allow for comparison of the experiences of participants in the two arms of the study. Analysis will follow the steps set out by Ritche and Spencer (1994); familiarisation, identifying a thematic framework, indexing, charting and mapping and interpretation.
- Conditions
- Dementia
- Being tested
- A guide to inform the process of delivering the outcomes of a dementia assessment, Usual Care
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
A guide to inform the process of delivering the outcomes of a dementia assessmentBehavioural
The guide provides information that informs the approach taken to assessing people for dementia. It aims to guide clinicians. patients and their companions to think about how the diagnostic process is carried out, taking into account patient preferences, particularly around how they would like diagnostic decisions to be communicated to them.
Usual CareBehavioural
Clinicians conduct the dementia assessment as per standard protocols
| Study group | Role | What they receive |
|---|---|---|
| Usual Care Dementia assessment | Active comparator | Clinicians will conduct the assessment and outcome process as per their usual practice. Receives: Behavioral: Usual Care |
| Guide informed dementia assessment | Experimental | The guide will be used by both clinicians, patients and their companions to inform the approach to the dementia assessment process. Receives: Behavioral: A guide to inform the process of delivering the outcomes of a dementia assessment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Difference in scores on The Consultation and Relational Empathy (CARE) Questionnaire for each condition
Measures patient and companions rating of clinician empathy in consultations. Higher scores suggest higher levels of clinician empathy. The maximum score possible is 50 and the minimum is 10.
Measured: Baseline
Difference in scores on The Consultation and Relational Empathy (CARE) Questionnaire for each condition
Measures patient and companions rating of clinician empathy in consultations. Higher scores suggest higher levels of clinician empathy. The maximum score possible is 50 and the minimum is 10.
Measured: Post initial Consultation. Up to four weeks following consultation appointment.
Difference in scores on The Consultation and Relational Empathy (CARE) Questionnaire for each condition
Measures patient and companions rating of clinician empathy in consultations. Higher scores suggest higher levels of clinician empathy. The maximum score possible is 50 and the minimum is 10.
Measured: Post outcome appointment. Up to four weeks following outcome appointment.
Qualitative semi-structured interviews with patients and companions.
Focussing on their experiences of the outcome appointment.
Measured: Interviews to take place following the outcome appointment. Up to four weeks following outcome appointment.
Qualitative semi-structured interviews with clinicians.
Focussing on their experiences of using the guide and delivering outcome appointments.
Measured: Interviews to take place within four weeks of clilnicians completing outcome appointments with all of the patients participating in the study.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jun 2021
- Study start21 Sep 2021
- Primary completion4 May 2022
- Study completion4 May 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DementiaStudies of the same condition, open and under way.
- More trials run by University of NottinghamThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 7 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Nottingham
- Sponsor type
- University, hospital or other
- Collaborators
- Northamptonshire Healthcare NHS Foundation Trust
- Responsible party
- Sponsor
- Investigators
- Danielle De Boos, Principal investigator, University of Nottingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04935060
- Sponsor's protocol ID
- 20077
- Status last verified
- Jun 2022
- First submitted
- 14 May 2021
- Last updated
- 13 Jun 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Acceptability and Feasibility of a Guide for Sharing the Outcome of a Memory Assessment
- ClinicalTrials.gov ID
- NCT04935060
- Acronym / sponsor ID
- 20077
- Conditions
- Dementia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 7 participants (actual)
- Lead sponsor
- University of NottinghamUniversity, hospital or other
- Collaborators
- Northamptonshire Healthcare NHS Foundation Trust
- Study start
- 21 Sep 2021 (actual)
- Primary completion
- 4 May 2022 (actual)
- Study completion
- 4 May 2022 (actual)
- First posted
- 22 Jun 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to establish the acceptability of a guide developed to improve people's experiences of dementia assessment outcome appointments in comparison to a standard consultation. This study will also inform the feasibility of future research evaluating the guide and provide information on how well the measurements used provide evaluation of the intervention.
Detailed description
Objectives:
To determine the acceptability of a guide supported consultation (intervention) for clinicians, patients and companions, in comparison to a standard diagnostic consultation (usual care).
To inform the feasibility of future research establishing recruitment processes and study uptake.
To establish how well the chosen measurement strategy provides evaluation of the intervention (including completion rates, perceived relevance and burdensomeness).
Setting:
NHS Secondary care, Memory Assessment Service (MAS). Services within the identified area are split into four teams. One team will provide the usual care treatment arm. Another team will provide the intervention arm.
Number of participants:
24 Patients and 24 Companions will be recruited for the quantitative component of the study.
Two clinicians and six participants will be recruited for the qualitative component of the study.
Description of interventions:
Baseline Measurement The Consultation and Relational Empathy (CARE) questionnaire and the adapted CARE (for companions) will be used to collect baseline data for each of the two sites. Baseline data will be collected from anyone attending outcome appointments at both sites during a recruitment period prior to the implementation of the intervention and will form an initial baseline cohort.
Quantitative Data Collection Usual Care Procedure The usual care procedure involves assessment of patient's cognitive abilities, daily functioning and physical health to determine the possibility of them having a dementia. This is done through a detailed history taking by MAS clinicians including information given by the patient, companions and information included from a GP referral. Standardised assessments are also conducted to inform the assessment process. These assessments are used based on the needs of the patient and companions involved. Access to scores on these assessments will be gained through their medical records and will provide a measurement for comparison between the two groups.
MAS outcome appointments are provided as part of routine care. These appointments require clinicians to rely on their professional judgement of the best way for the outcomes of assessments to be communicated to patients and their companions. There are no current standardised guidelines used within the service for this purpose.
In addition to the service's usual practice, participants will be asked to complete the CARE and the adapted CARE following their initial assessment and their outcome appointment. The completed questionnaires will be returned to the researcher by post via pre-paid envelope. A reminder via telephone call will be given to participants on the day following their appointment and if they haven't completed the questionnaire they will be given the opportunity to complete it whilst on the call with the researcher.
Intervention Procedure The intervention procedure will follow the same steps as the usual care procedure with the addition of use of the Bennett, De Boos and Moghaddam (2018) guide for clinicians, patients and companions. After gaining of written consent at the initial assessment appointment, the clinician will give the patient a copy of the guide and inform them that they can share this with their companion should they wish to. When conducting outcome appointments clinicians will use the guide to inform communication with the patient and companion. Clinicians will also refer patients and companions to their copy of the guide during the outcome appointment.
Qualitative Data Collection Qualitative data will be collected using semi-structured interviews with patients and companions as well as clinicians focussing on their experiences of the outcome appointment. Individuals taking part in the interviews will be involved will therefore be involved with the study for a further four weeks.
Duration of study:
Overall: March 2021-February 2022 Participants and companions involvement with the study will be for the duration of their assessment by the MAS teams. This is usually around 16 weeks but varies depending on the clinical needs of the patient. Participants taking part in the additional qualitative interview will extend the duration of their involvement in the study by up to four weeks.
Statistical Methods Quantitative data analysis Quantitative analysis will be descriptive and will aim to give confidence interval estimation. Baseline measures will be collected for each location to allow estimates of the variability between the two sites for comparison.
Intra Class Correlations (ICCs) will be carried out to examine the degree of clustering. Intention to treat (ITT) analysis will be carried out to give a more accurate estimate of effectiveness in clinical practice. Participants data will be analysed based on their experimental arm allocation.
Intra Class Correlations (ICCs) will be carried out to examine the degree of clustering. Intention to treat (ITT) analysis will be carried out to give a more accurate estimate of effectiveness in clinical practice. Participants data will be analysed based on their experimental arm allocation.
Viability of recruitment will be assessed using eligibility and consent rates for patients and clinicians. The burden of measure completion will be assessed through missing data levels as well as interviews with patients and clinicians. Withdrawal rates post consent will be calculated by study arm for use in future sample size calculations.
Qualitative data analysis A framework method, as set out by Ritchie and Spencer (1994), will be used to identify themes. This will allow for comparison of the experiences of participants in the two arms of the study. Analysis will follow the steps set out by Ritche and Spencer (1994); familiarisation, identifying a thematic framework, indexing, charting and mapping and interpretation.
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Usual Care Dementia assessment | Active comparator | Behavioral: Usual CareClinicians will conduct the assessment and outcome process as per their usual practice. |
| Guide informed dementia assessment | Experimental | Behavioral: A guide to inform the process of delivering the outcomes of a dementia assessmentThe guide will be used by both clinicians, patients and their companions to inform the approach to the dementia assessment process. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (11 listed)
- Taking part in an initial assessment appointment with the participating MAS services
- Aged 18 years or over (Northamptonshire MAS require patients to be 65 years or over to be eligible for referral. There will be no upper age limit)
- Able to provide written informed consent
- Supporting a patient-participant to attend a MAS initial assessment appointment
- Aged 18 years or over
Key exclusion criteria (2 listed)
- Patients and companions will not be included in the research if there is reason to doubt their capacity to give informed consent under the Mental Capacity Act 2005.
- Patients and companions who are not fluent in English will not be included in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| A guide to inform the process of delivering the outcomes of a dementia assessmentThe guide provides information that informs the approach taken to assessing people for dementia. It aims to guide clinicians. patients and their companions to think about how the diagnostic process is carried out, taking into account patient preferences, particularly around how they would like diagnostic decisions to be communicated to them. | Behavioural | Guide informed dementia assessment |
| Usual CareClinicians conduct the dementia assessment as per standard protocols | Behavioural | Usual Care Dementia assessment |
Primary outcome
Difference in scores on The Consultation and Relational Empathy (CARE) Questionnaire for each condition
Time frame: Baseline
Measures patient and companions rating of clinician empathy in consultations. Higher scores suggest higher levels of clinician empathy. The maximum score possible is 50 and the minimum is 10.
Difference in scores on The Consultation and Relational Empathy (CARE) Questionnaire for each condition
Time frame: Post initial Consultation. Up to four weeks following consultation appointment.
Measures patient and companions rating of clinician empathy in consultations. Higher scores suggest higher levels of clinician empathy. The maximum score possible is 50 and the minimum is 10.
Difference in scores on The Consultation and Relational Empathy (CARE) Questionnaire for each condition
Time frame: Post outcome appointment. Up to four weeks following outcome appointment.
Measures patient and companions rating of clinician empathy in consultations. Higher scores suggest higher levels of clinician empathy. The maximum score possible is 50 and the minimum is 10.
Qualitative semi-structured interviews with patients and companions.
Time frame: Interviews to take place following the outcome appointment. Up to four weeks following outcome appointment.
Focussing on their experiences of the outcome appointment.
Qualitative semi-structured interviews with clinicians.
Time frame: Interviews to take place within four weeks of clilnicians completing outcome appointments with all of the patients participating in the study.
Focussing on their experiences of using the guide and delivering outcome appointments.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jun 2022.
- Individual participant dataSharing planned: No
Related trials for Dementia
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Danielle De Boos principal investigator
University of Nottingham
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing A guide to inform the process of delivering the outcomes of a dementia assessment in people with Dementia, run by University of Nottingham at 2 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Difference in scores on The Consultation and Relational Empathy (CARE) Questionnaire for each condition (time frame: Baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2022.